Supernus Pharmaceuticals (SUPN) Cash from Operations (QoQ) (2011 - 2026)
Supernus Pharmaceuticals (SUPN) Cash from Operations (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 92.16 Bn | 90.29 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.38 Bn | 32.64 Bn | 1.97 Bn |
| 3 | Zoetis | 32.90 Bn | 30.96 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.82 Bn | 20.66 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.75 Bn | 22.75 Bn | - |
| 7 | Viatris | 20.58 Bn | 18.78 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.26 Bn | 16.94 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.76 Bn | 12.33 Bn | 785.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.71 Bn | 2.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.95% |
| Dec 31, 2025 | 132.21% |
| Sep 30, 2025 | -205.35% |
| Jun 30, 2025 | 91.30% |
| Mar 31, 2025 | -31.09% |
| Dec 31, 2024 | -17.03% |
| Sep 30, 2024 | 50.24% |
| Jun 30, 2024 | -7.23% |
| Mar 31, 2024 | -14.58% |
| Dec 31, 2023 | 25.32% |
| Sep 30, 2023 | 290.08% |
| Jun 30, 2023 | -138.42% |
| Mar 31, 2023 | 78.23% |
| Dec 31, 2022 | 99.15% |
| Sep 30, 2022 | -80.54% |
| Jun 30, 2022 | 1,553.16% |
| Mar 31, 2022 | -91.18% |
| Dec 31, 2021 | 1,286.45% |
| Sep 30, 2021 | -108.88% |
| Jun 30, 2021 | 27.83% |